#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medulloblastoma Haematological malignancy IPEX syndrome Hypersomnia Desmoplastic small round cell tumour Small cell lung cancer Fibrosarcoma Vascular calcification Cold type haemolytic anaemia Haemophilia A without inhibitors Renal cancer metastatic Nephropathy Hairy cell leukaemia Immune-mediated myasthenia gravis Precursor T-lymphoblastic lymphoma/leukaemia recurrent More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis I – Diagnostics Haemophagocytic lymphohistiocytosis – Trials in Disease Hepatoblastoma Tuberous sclerosis complex Von Willebrand’s disease – Treatment Systemic sclerosis pulmonary – Trials in Disease Cerebral arteriovenous malformation haemorrhagic – Diagnostics CADASIL – Treatment Waldenstrom’s macroglobulinaemia – Treatment Lymphangioma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Povidone, Iodinated Tebentafusp AZD0022 Resatorvid Camphor Bleomycin Sulfate Ph. Eur. Ds-2325A Olmesartan Medoxomil Omo-103 Op-1250 Nitrous Oxide Imatinib Mesilate Safinamide Milrinone Lurasidone Paeonol Remibrutinib Liquid Paraffin Rilpivirine Hydrochloride Mk-2060 More therapies…

    Learn about Your Condition

    Acute cardiac event Corneal graft rejection Adenocarcinoma pancreas Head and neck cancer stage IV Dyspnoea Bronchostenosis Testicular leiomyosarcoma Testicular germ cell cancer Osteoarthritis Leukocyte adhesion deficiency Endometrial cancer stage III Herpes zoster Richter's syndrome Tendon rupture Neuroblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Sud Francilien

Centre Hospitalier Sud Francilien

40 Avenue Serge Dassault, Corbeil Essonnes, 91100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Comparing Anakinra versus Immunoglobulin for Treatment-Resistant Kawasaki Disease in Patients Who Failed Initial Immunoglobulin Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Kawasaki’s disease
    Investigated Drugs:
    • Anakinra
    • Human Normal Immunoglobulin
    France

  • Comparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Peginterferon Alfa-2A
    • Hydroxycarbamide
    • Ruxolitinib
    France

  • A Study of Levetiracetam for Prevention and Treatment of Delirium in Adult ICU Patients with Septic Shock

    Recruiting

    3 1 1
    Investigated Drugs:
    • Levetiracetam
    • Sodium Chloride
    France

  • Study on Treating Acute Osteomyelitis in Children with Amoxicillin and Cloxacillin Compared to Standard Hospital Care

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteomyelitis
    • Osteomyelitis acute
    Investigated Drugs:
    • Cefazolin
    • Cloxacillin
    • Clavulanic Acid
    France

  • Study on Using Desmopressin Acetate Trihydrate to Prevent Sodium Overcorrection in Patients with Severe Hyponatremia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Meglumine Gadoterate
    • Glucose Monohydrate
    • Sodium Lactate
    France

  • Study on Norepinephrine for Improving Outcomes in Patients with Acute Progressive Stroke

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Noradrenaline Tartrate
    France

  • Study on the Effectiveness of Chemotherapy with Folinic Acid, Fluorouracil, and Irinotecan for Patients with Stage III Colon Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    France

  • Study of Intranasal Sufentanil and Intravenous Morphine for Severe Sickle Cell Pain Crisis in Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • Morphine Hydrochloride
    • Sufentanil
    • Sodium Chloride
    France

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Idarubicin
    • Cytarabine
    • Daunorubicin
    France

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Brentuximab Vedotin
    • Etoposide
    Belgium France
Previous Page
1 2 3 4 … 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!